Patients who have undergone internal bra procedures with breast mesh are increasingly reporting alleged complications like chronic pain, infection, and the need for additional surgeries. These mesh implants, designed to support weakened breast tissue and improve the longevity of breast lifts or augmentations, are now at the center of product liability claims alleging potential safety risks and inadequate warnings.
Patients Allege Complications from Internal Bra Procedures
The “internal bra” technique involves implanting a surgical mesh device beneath breast tissue to act as a supportive scaffold. While it has been used in both cosmetic and reconstructive procedures, some patients now claim that the devices may have led to unexpected medical issues.
Plaintiffs allege that certain breast mesh products used in internal bra procedures did not perform as expected and may have introduced additional health risks. A growing number of breast mesh lawsuits claim that manufacturers allegedly overstated the benefits of the devices or failed to fully disclose potential complications.
Side Effects Allegedly Linked to Breast Mesh Implants
Patients have reported symptoms ranging from discomfort to more severe complications requiring surgical intervention. Injuries detailed in breast mesh lawsuits include infection, mesh rejection, and tissue damage. Some patients also report that the mesh shifted from its original placement, affecting both function and appearance. While these claims are still being evaluated in court, the growing number of internal bra lawsuits has drawn attention to the broader safety profile of surgical mesh used in breast procedures.
What Medical Research Says About Surgical Mesh
Although internal bra procedures are relatively newer in cosmetic applications, surgical mesh has been studied extensively in other areas of medicine. Research has identified both benefits and potential risks, particularly related to how the body responds to implanted materials.
In a 2024 study published in the Aesthetic Surgery Journal, researchers examined the use of mesh implants in alloplastic breast reconstruction, an off-label use not specifically approved by the FDA. The study reviewed outcomes across multiple prior studies and found that while mesh can provide structural support, reported complications included infection, seroma, reoperation, and explant in some patients.
Another systematic review of breast reconstruction studies published in 2023 evaluated complication rates associated with mesh implants, including infection, seroma, capsular contracture, and major complications such as reoperation or implant removal, though outcomes varied depending on the type of mesh used.
FDA Warnings Raise Broader Concerns About Mesh Implants
Concerns about potential surgical mesh injuries are not limited to breast procedures. The U.S. Food and Drug Administration (FDA) has issued multiple safety communications regarding mesh implants used in other parts of the body, particularly transvaginal mesh for pelvic organ prolapse (POP).
In 2019, the FDA ordered manufacturers to stop selling certain transvaginal mesh products after determining that they did not demonstrate reasonable assurance of safety and effectiveness. “Based on the review of available evidence, the FDA continues to believe the benefits do not outweigh the risks of surgical mesh placed transvaginally to treat POP,” the FDA stated. The agency cited potential risks including pain, infection, mesh erosion, and the need for additional surgeries.
Potential Breast Mesh Injury Symptoms
While transvaginal mesh is a different application, the FDA’s findings have raised broader questions about how mesh behaves in the body and whether similar risks could be present in other uses, including breast procedures. The alleged complications reported in internal bra injury claims are similar to those documented in other types of mesh implants. Patients have alleged:
- Chronic pain that interferes with daily life
- Infections that may require antibiotics or surgical removal
- Immune reactions where the body rejects the mesh
- Tissue damage or thinning around the implant site
- Hardening or tightening of breast tissue
- Movement or migration of the mesh
In more severe cases, patients report undergoing revision surgeries to remove or replace the surgical mesh. These procedures can be complex and may not fully resolve the symptoms.
What Patients Should Know About Breast Mesh Procedures
Patients who have undergone an internal bra procedure and are experiencing one or more alleged breast mesh injuries are encouraged to seek medical evaluation. Early diagnosis and treatment may help address potential complications and prevent further issues.
As breast mesh lawsuits move forward and additional research continues, future developments involving breast mesh procedures will be closely monitored. Experts note that patient internal bra surgery outcomes can vary widely depending on individual factors, the type of mesh used, and surgical technique. In the meantime, patients and providers alike are being encouraged to weigh the potential benefits and risks of these procedures and to stay informed as more data regarding the safety of internal bra mesh becomes available.
Breast Mesh Lawsuit Information
Comparing Complications of Biologic and Synthetic Mesh in Breast Reconstruction: A Systematic Review and Network Meta-Analysis, Thieme Open Access
Pelvic Organ Prolapse (POP): Surgical Mesh Considerations and Recommendations, FDA
Breast Mesh Lawsuit, Leading Justice

